Bain Capital Life Sciences Investors’s Frazier Lifesciences Acquisition Corporation Unit FLACU Stock Holding History

Bain Capital Life Sciences Investors’s Portfolio FLACU Stock Details FLACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-300,000	Closed	-$3.04M	–	36
2022 Q3	$3.04M	Hold	300,000	–	–	0.36%	32
2022 Q2	$2.96M	Hold	300,000	–	–	0.35%	33
2022 Q1	$3M	Hold	300,000	–	–	0.29%	33
2021 Q4	$2.98M	Hold	300,000	–	–	0.24%	33
2021 Q3	$3.01M	Hold	300,000	–	–	0.19%	31
2021 Q2	$3.02M	Hold	300,000	–	–	0.2%	28
2021 Q1	$3.05M	Hold	300,000	–	–	0.17%	29
2020 Q4	$3.11M	Buy	+300,000	New	+$3.13M	0.2%	24

Bain Capital Life Sciences Investors's FLACU Position: Q4 2022 in Review

Bain Capital Life Sciences Investors sold out of Frazier Lifesciences Acquisition Corporation Unit (FLACU) in Q4 2022, closing a stake of 300,000 shares — an estimated $3.04M sold.

Bain Capital Life Sciences Investors first reported a position in FLACU in Q4 2020 and held it in 8 quarters. The position peaked at $3.11M in Q4 2020. 0 funds tracked by Wall St. Rank hold FLACU as of Q4 2022.

Bain Capital Life Sciences Investors reported no remaining Frazier Lifesciences Acquisition Corporation Unit position as of Q4 2022 after selling out during the quarter.
Bain Capital Life Sciences Investors sold 300,000 Frazier Lifesciences Acquisition Corporation Unit shares in Q4 2022, an estimated $3.04M.
Bain Capital Life Sciences Investors first reported a position in Frazier Lifesciences Acquisition Corporation Unit in Q4 2020 and held it in 8 quarters.
Bain Capital Life Sciences Investors's Frazier Lifesciences Acquisition Corporation Unit position peaked at $3.11M in Q4 2020.
0 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Unit as of Q4 2022.

Based on Bain Capital Life Sciences Investors's 13F filing for Q4 2022, filed 14 Feb 2023.